Lancashire and South Cumbria
Formulary
Formulary
13 Skin
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents: mlcsu.lscformulary@nhs.net.
For more information about the formulary development process, please see: https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
13-06 Acne and rosacea
| Brimonidine Gel Mirvaso® |
|
Restricted
|
3mg/g gel brimonidine tartrate (Only for use in patients with moderate to severe, persistent facial erythema of rosacea) |
|
| Ivermectin cream Soolantra® |
|
Formulary
|
Cream 10mg/g
Topical treatment of inflammatory lesions of rosacea (papulopustular) in adults.
Appropriate for initiation and on-going prescribing in both primary and secondary care. To be used as an alternative treatment when metronidazole and azelaic acid topical preparations are not effective, contraindicated or not tolerated by the patient. Ivermectin cream may be tried for a 3 month period, at which point it can be stopped if not effective or continued if effective. |
 NICE: Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream |
|
Links
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE new medicine summary: Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE NG198: Acne vulgaris: management
- NICE: Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream